Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]

Abstract

Loutfy SA, Elberry MH, Farroh KY, et al. Int J Nanomedicine. 2020;15:2699–2715.The authors have advised Figure 8 on page 2712 is incorrect. The correct Figure 8 is shown below.The authors apologize for this error and advise it does not affect the results of the paperRead the original article

Keywords

• caspase-dependent pathway
• chitosan curcumin nanocomposite
• hepatitis c virus 4a
• huh7
• docking